Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

NCT06540950 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Vinorelbine

Interventions

DRUG: vinorelbine

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences